Biohacking Market Research Report - Global forecast till 2023

Biohacking Market Research Report - Global forecast till 2023

ID: MRFR/HC/3719-CRR | December, 2017 | Region: Global | 157 pages | Cooked Research Reports

Biohacking Market Information: By Type (Outside Biohacking, Inside Biohacking), By Devices (Sensors, Smart Drugs, Strains), Indication (Synthetic Biology, Genetic Engineering, Forensics Sciences), End User- Global Forecast till 2023 


Market Synopsis of the Global Biohacking Market 


Biohacking refers to managing one's own biology using a combination of medical, nutritional and electronic techniques. Biohackers are people who perform lab experiments to explore new possibilities of biotechnology, molecular biology, genetic engineering and many other aspects of biology. They undertake number of various experimentation on the body, for instance, inserting microchips to control stress level or monitor heart rate. 


Microchip is a unit of packaged computer circuitry, manufactured from a material such as silicon. They are made of microprocessors and for computer memory and are also used for various purposes such as such as analog-to-digital conversion, bit slicing, and gateways. Implanting microchips into the human body can transform number of daily activities a person does. The size these microchips is as small as a rice grain that can be easily implanted under the skin. Most of the bio hackers get these implanted into their skin which makes their tasks easier than ever before. For instance, opening a security lock or door.


Bio hackers have developed number of products exploring the body and mind, which will benefit the mankind. Some of the revolutionary products are microchips, smart drugs, magnetic fingertips, RFID implants, brain sensors, bacterial and yeast strains, health tracker, body sensors, smart blood pressure monitor and many others. 


The global biohacking market is mainly driven by rising awareness about biohacking, increasing prevalence of chronic diseases, and extensive demand smart devices and drugs across the globe. Furthermore, presence of prominent market players also influences the growth of the market. However, the market growth of the market is restrained by lack of cyber security practices.


The global biohacking market is expected to grow at a CAGR of 19.42% during the forecast period. 


Intended Audience



  • Biopsy Devices Manufacturers

  • Biopsy Devices Suppliers

  • Private Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Government Research Laboratories


Segments                                                                                                                                            


The global biohacking market is segmented on the basis of type, product, application, and end user.


On the basis of type, the market is segmented into outside biohacking and inside biohacking.


On the basis of product, the market is segmented into smart drugs, sensors, strains, and others.


On the basis of application, the market is segmented into synthetic biology, genetic engineering, forensic science, diagnosis & treatment, drug testing, and others.


On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, forensic laboratories, and others.


Regional Analysis of the Global Biohacking Market    


Geographically, the global biohacking market is segmented into four regions namely Americas, Europe, Asia Pacific and the Middle East and Africa.


Americas hold the significant market share in biohacking owing the presence of large number of biotechnology and synthetic biology companies engaged in the product of innovative products. Many of these companies manufacturing bacterial strains, lab equipment’s and accessories used in hacklabs. Large number of conferences are organized by a number of biohacking groups and organizations encouraging the youth to do research in the field of biotechnology.


Europe is regarded as the second largest market for biohacking. In Europe, the market for biohacking is found to be growing steadily. The major restrain for the growth of this market in the Europe is strict regulations governing biohacking. For instance, European groups need to obtain license from the government to carry out genetic engineering experiments.


Asia Pacific region is expected to grow at a steady rate owing to an increasing demand for smart devices and sensor, rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, neurological diseases, and growth of healthcare industry in the market. As per the WHO, cardiovascular diseases are of the major cause of mortality in India. In 2015, there were nearly 30 million heart patients and the burden is expected to increase in the further, surpassing other countries across the globe. Additionally, diabetes is another major chronic disease among the geriatric population in Asia Pacific.


Middle East & Africa show slow growth in the biohacking market. The market is driven by increasing demand for smart devices, changing lifestyle, and rising prevalence of obesity, diabetes and cardiovascular diseases. Egypt, United Arab Emirates (UAE), Kuwait, and Saudi Arabia have high prevalence of obesity. Furthermore, prevalence of obesity in found to be high among adults and children, which is of great concern. However, technology penetration is found to low in various parts for Africa. Biohack.ae is company currently working on biohacking which manufactures supplements, mushrooms, MCT oils and healthy fats, smart drugs, proteins, and coffee.


FIGURE 1: Global Biohacking Market by Region, 2016 (%)

Biohacking Market


Sources: U.S. National Library of Medicine, National Centre for Biotechnology Information, U.S. Centres for Medicare & Medicaid Services, Directorate of Industries, Expert Interviews, Annual report, White paper, Company Presentation


 


Key Players in the Global Biohacking Market  


The global biohacking market has evolved from last few years with emergence of new players in the market. Along with extensive research, key players have adopted the strategy of product launch in the market. The major focus to the companies is on the development of new biohacking tools, kits, and devices that can be used by biohackers. These products are smart drugs, sensors, and bacterial strains having wide application in synthetic biology, and genetics.


Some of the major players in the global Biohacking market are Fitbit, Inc. (U.S.), Apple (U.S.), Synbiota (Canada), THE ODIN (U.S.), HVMN, Inc. (U.S.), Thync Global Inc., U.S.A. (U.S.), Moodmetric (U.S.), and others.


Research Methodology

Global Biohacking Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 


 

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

2.1 Introduction 19

2.2 Scope of Study 19

2.3 Research Objective 20

2.4 Assumptions & Limitations 20

2.4.1 Assumptions 20

2.4.2 Limitations 20

2.5 Market Structure 21

3.1.1 Primary Research Methodology 23

3.1.2 Secondary Research Methodology 24

3.1.3 Market Share Analysis 25

3.1.4 Trade Analysis 25

3.2 Forecast Model 26

4.1 Introduction 27

4.2 Drivers 28

4.2.1 Rising prevalence of chronic disease (45%) 28

4.2.2 Growing awareness about biohacking (25%) 29

4.2.3 Increasing demand for innovative medical devices and sensors (30%) 30

4.3 Restraints 31

4.3.1 Lack of cyber security practices 31

4.4 Opportunities 32

4.4.1 Technological advancement 32

4.5 Mega Trends 32

4.5.1 Exploration of future biohacking products on rise 32

4.6 Macroeconomic indicators 33

5.1 Value Chain Analysis 34

5.1.1 Primary activities 34

5.1.2 Secondary activities 35

5.2 Porters Five Forces Model 36

5.2.1 Bargaining Power of Suppliers 37

5.2.2 Bargaining Power of Buyers 37

5.2.3 Threat of New Entrants 37

5.2.4 Threat of Substitutes 37

5.2.5 Intensity of Rivalry 38

6.1 Introduction 39

6.2 Outside Biohacking 40

6.3 Inside Biohacking 40

7.1 Introduction 41

7.2 Smart Drugs 42

7.3 Sensors 44

7.4 Strains 45

7.5 Others 46

8.1 Introduction 47

8.2 Synthetic Biology 48

8.3 Genetic Engineering 49

8.4 Forensic science 51

8.5 Diagnosis & Treatment 51

8.6 Drug testing 53

8.7 Others 53

9.1 Introduction 54

9.2 Pharmaceutical & Biotechnology Companies 55

9.3 Forensic Laboratories 55

9.4 Others 56

10.1 Introduction 57

10.2 Americas 58

10.2.1 U.S. 63

10.2.2 Canada 65

10.2.3 South America 68

10.3 Europe 72

10.3.1 Germany 76

10.3.2 France 79

10.3.3 U.K 82

10.3.4 Italy 85

10.3.5 Spain 88

10.3.6 Rest of Western Europe 91

10.3.7 Eastern Europe 94

10.4 Asia Pacific 98

10.4.1 Japan 103

10.4.2 China 105

10.4.3 India 108

10.4.4 Australia 111

10.4.5 Republic of Korea 114

10.4.6 Rest of Asia Pacific 117

10.5 Middle East & Africa 121

10.5.1 United Arab Emirates 125

10.5.2 Saudi Arabia 128

10.5.3 Oman 131

10.5.4 Kuwait 134

10.5.5 Qatar 137

10.5.6 Rest of Middle East & Africa 140

11.1 Introduction: Key Players 144

11.2 Company Share Analysis 144

12.1 Fitbit, Inc. 145

12.1.1 Company Overview 145

12.1.2 Financials 145

12.1.3 Products 145

12.1.4 Strategy 145

12.1.5 Key Developments 145

12.2 Apple 146

12.2.1 Company Overview 146

12.2.2 Financials 146

12.2.3 Products 146

12.2.4 Strategy 146

12.2.5 Key Developments 146

12.3 Synbiota 147

12.3.1 Company Overview 147

12.3.2 Financials 147

12.3.3 Products 147

12.3.4 Strategy 147

12.3.5 Key Developments 147

12.4 THE ODIN 148

12.4.1 Company Overview 148

12.4.2 Financials 148

12.4.3 Products 148

12.4.4 Strategy 148

12.4.5 Key Developments 148

12.5 HVMN, Inc. 149

12.5.1 Company Overview 149

12.5.2 Financials 149

12.5.3 Products 149

12.5.4 Strategy 149

12.5.5 Key Developments 149

12.6 Thync Global Inc., U.S.A. 150

12.6.1 Company Overview 150

12.6.2 Financials 150

12.6.3 Products 150

12.6.4 Strategy 150

12.6.5 Key Developments 150

12.7 MoodMetric 151

12.7.1 Company Overview 151

12.7.2 Financials 151

12.7.3 Products 151

12.7.4 Strategy 151

12.7.5 Key Developments 151

13.1 Key Findings 152

13.1.1 CEO’s Viewpoint 152

13.1.2 Unmet Needs 152

13.1.3 Key Companies to Watch 152

13.1.4 Prediction of Biohacking Industry 152

14.1 Discussion Blue Print 154

14.2 References 156

TABLE 1 PRIMARY INTERVIEWS 23

TABLE 2 GLOBAL BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 39

TABLE 3 GLOBAL BIOHACKING MARKET FOR OUTSIDE BIOHACKING BY REGION, 2014 TO 2023 (USD MILLION) 40

TABLE 4 GLOBAL BIOHACKING MARKET FOR INSIDE BIOHAKCING, BY REGION, 2014 TO 2023 (USD MILLION) 40

TABLE 5 GLOBAL BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 41

TABLE 6 GLOBAL SMART DRUGS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 43

TABLE 7 GLOBAL SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 43

TABLE 8 GLOBAL SENSORS MARKET BY REGION, 2014 TO 2023 (USD MILLION) 44

TABLE 9 GLOBAL STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 45

TABLE 10 GLOBAL STRAINS MARKET BY REGION, 2014 TO 2023 (USD MILLION) 45

TABLE 11 GLOBAL BIOHACKING MARKET BY OTHER PRODUCT, 2014 TO 2023 (USD MILLION) 46

TABLE 12 GLOBAL BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 47

TABLE 13 GLOBAL BIOHACKING MARKET FOR SYNTHETIC BIOLOGY, BY REGION, 2014 TO 2023 (USD MILLION) 49

TABLE 14 GLOBAL BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 50

TABLE 15 GLOBAL BIOHACKING MARKET FOR GENETIC ENGINEERING, BY REGION, 2014 TO 2023 (USD MILLION) 50

TABLE 16 GLOBAL BIOHACKING MARKET FOR FORENSIC SCIENCE, BY REGION, 2014 TO 2023 (USD MILLION) 51

TABLE 17 GLOBAL BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 52

TABLE 18 GLOBAL BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY REGION, 2014 TO 2023 (USD MILLION) 52

TABLE 19 GLOBAL BIOHACKING MARKET FOR DRUG TESTING, BY REGION, 2014 TO 2023 (USD MILLION) 53

TABLE 20 GLOBAL BIOHACKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2014 TO 2023 (USD MILLION) 53

TABLE 21 GLOBAL BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 54

TABLE 22 GLOBAL BIOHACKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES BY REGION, 2014 TO 2023 (USD MILLION) 55

TABLE 23 GLOBAL BIOHACKING MARKET FOR FORENSIC LABORATORIES BY REGION, 2014 TO 2023 (USD MILLION) 55

TABLE 24 GLOBAL BIOHACKING MARKET FOR OTHER END USERS BY REGION, 2014 TO 2023 (USD MILLION) 56

TABLE 25 GLOBAL BIOHACKING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 57

TABLE 26 AMERICAS BIOHACKING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 58

TABLE 27 NORTH AMERICA BIOHACKING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 58

TABLE 28 AMERICAS BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 59

TABLE 29 AMERICAS BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 59

TABLE 30 AMERICAS SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 60

TABLE 31 AMERICAS STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 60

TABLE 32 AMERICAS BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 61

TABLE 33 AMERICAS BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 61

TABLE 34 AMERICAS BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 62

TABLE 35 AMERICAS BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 62

TABLE 36 U.S. BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 63

TABLE 37 U.S. BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 63

TABLE 38 U.S. SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 63

TABLE 39 U.S. STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 64

TABLE 40 U.S. BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 64

TABLE 41 U.S. BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 64

TABLE 42 U.S. BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 65

TABLE 43 U.S. BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 65

TABLE 44 CANADA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 65

TABLE 45 CANADA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 66

TABLE 46 CANADA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 66

TABLE 47 CANADA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 66

TABLE 48 CANADA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 67

TABLE 49 CANADA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 67

TABLE 50 CANADA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 68

TABLE 51 CANADA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 68

TABLE 52 SOUTH AMERICA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 68

TABLE 53 SOUTH AMERICA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 69

TABLE 54 SOUTH AMERICA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 69

TABLE 55 SOUTH AMERICA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 69

TABLE 56 SOUTH AMERICA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 70

TABLE 57 SOUTH AMERICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 70

TABLE 58 SOUTH AMERICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 71

TABLE 59 SOUTH AMERICA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 71

TABLE 60 EUROPE BIOHACKING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 72

TABLE 61 WESTERN EUROPE BIOHACKING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 73

TABLE 62 EUROPE BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 74

TABLE 63 EUROPE BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 74

TABLE 64 EUROPE SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 74

TABLE 65 EUROPE STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 75

TABLE 66 EUROPE BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 75

TABLE 67 EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 75

TABLE 68 EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 76

TABLE 69 EUROPE BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 76

TABLE 70 GERMANY BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 76

TABLE 71 GERMANY BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 77

TABLE 72 GERMANY SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 77

TABLE 73 GERMANY STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 77

TABLE 74 GERMANY BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 78

TABLE 75 GERMANY BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 78

TABLE 76 GERMANY BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 79

TABLE 77 GERMANY BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 79

TABLE 78 FRANCE BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 79

TABLE 79 FRANCE BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 80

TABLE 80 FRANCE SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 80

TABLE 81 FRANCE STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 80

TABLE 82 FRANCE BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 81

TABLE 83 FRANCE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 81

TABLE 84 FRANCE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 82

TABLE 85 FRANCE BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 82

TABLE 86 U.K BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 82

TABLE 87 U.K BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 83

TABLE 88 U.K SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 83

TABLE 89 U.K STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 83

TABLE 90 U.K BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 84

TABLE 91 U.K BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 84

TABLE 92 U.K BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 84

TABLE 93 U.K BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 85

TABLE 94 ITALY BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 85

TABLE 95 ITALY BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 85

TABLE 96 ITALY SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 86

TABLE 97 ITALY STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 86

TABLE 98 ITALY BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 87

TABLE 99 ITALY BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 87

TABLE 100 ITALY BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 88

TABLE 101 ITALY BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 88

TABLE 102 SPAIN BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 88

TABLE 103 SPAIN BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 89

TABLE 104 SPAIN SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 89

TABLE 105 SPAIN STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 89

TABLE 106 SPAIN BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 90

TABLE 107 SPAIN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 90

TABLE 108 SPAIN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 91

TABLE 109 SPAIN BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 91

TABLE 110 REST OF WESTERN EUROPE BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 91

TABLE 111 REST OF WESTERN EUROPE BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 92

TABLE 112 REST OF WESTERN EUROPE SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 92

TABLE 113 REST OF WESTERN EUROPE STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 92

TABLE 114 REST OF WESTERN EUROPE BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 93

TABLE 115 REST OF WESTERN EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 93

TABLE 116 REST OF WESTERN EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 94

TABLE 117 REST OF WESTERN EUROPE BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 94

TABLE 118 EASTERN EUROPE BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 94

TABLE 119 EASTERN EUROPE BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 95

TABLE 120 EASTERN EUROPE SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 95

TABLE 121 EASTERN EUROPE STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 95

TABLE 122 EASTERN EUROPE BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 96

TABLE 123 EASTERN EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 96

TABLE 124 EASTERN EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 97

TABLE 125 EASTERN EUROPE BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 97

TABLE 126 ASIA PACIFIC BIOHACKING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 99

TABLE 127 ASIA PACIFIC BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 99

TABLE 128 ASIA PACIFIC BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 100

TABLE 129 ASIA PACIFIC SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 100

TABLE 130 ASIA PACIFIC STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 100

TABLE 131 ASIA PACIFIC BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 101

TABLE 132 ASIA PACIFIC BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 101

TABLE 133 ASIA PACIFIC BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 102

TABLE 134 ASIA PACIFIC BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 102

TABLE 135 JAPAN BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 103

TABLE 136 JAPAN BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 103

TABLE 137 JAPAN SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 103

TABLE 138 JAPAN STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 104

TABLE 139 JAPAN BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 104

TABLE 140 JAPAN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 104

TABLE 141 JAPAN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 105

TABLE 142 JAPAN BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 105

TABLE 143 CHINA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 105

TABLE 144 CHINA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 106

TABLE 145 CHINA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 106

TABLE 146 CHINA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 106

TABLE 147 CHINA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 107

TABLE 148 CHINA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 107

TABLE 149 CHINA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 108

TABLE 150 CHINA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 108

TABLE 151 INDIA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 108

TABLE 152 INDIA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 109

TABLE 153 INDIA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 109

TABLE 154 INDIA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 109

TABLE 155 INDIA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 110

TABLE 156 INDIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 110

TABLE 157 INDIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 111

TABLE 158 INDIA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 111

TABLE 159 AUSTRALIA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 111

TABLE 160 AUSTRALIA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 112

TABLE 161 AUSTRALIA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 112

TABLE 162 AUSTRALIA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 112

TABLE 163 AUSTRALIA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 113

TABLE 164 AUSTRALIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 113

TABLE 165 AUSTRALIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 114

TABLE 166 AUSTRALIA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 114

TABLE 167 REPUBLIC OF KOREA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 114

TABLE 168 REPUBLIC OF KOREA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 115

TABLE 169 REPUBLIC OF KOREA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 115

TABLE 170 REPUBLIC OF KOREA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 115

TABLE 171 REPUBLIC OF KOREA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 116

TABLE 172 REPUBLIC OF KOREA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 116

TABLE 173 REPUBLIC OF KOREA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 117

TABLE 174 REPUBLIC OF KOREA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 117

TABLE 175 REST OF ASIA PACIFIC BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 117

TABLE 176 REST OF ASIA PACIFIC BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 118

TABLE 177 REST OF ASIA PACIFIC SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 118

TABLE 178 REST OF ASIA PACIFIC STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 118

TABLE 179 REST OF ASIA PACIFIC BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 119

TABLE 180 REST OF ASIA PACIFIC BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 119

TABLE 181 REST OF ASIA PACIFIC BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 120

TABLE 182 REST OF ASIA PACIFIC BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 120

TABLE 183 MIDDLE EAST & AFRICA BIOHACKING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 121

TABLE 184 MIDDLE EAST & AFRICA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 122

TABLE 185 MIDDLE EAST & AFRICA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 122

TABLE 186 MIDDLE EAST & AFRICA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 123

TABLE 187 MIDDLE EAST & AFRICA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 123

TABLE 188 MIDDLE EAST & AFRICA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 124

TABLE 189 MIDDLE EAST & AFRICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 124

TABLE 190 MIDDLE EAST & AFRICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 125

TABLE 191 MIDDLE EAST & AFRICA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 125

TABLE 192 UNITED ARAB EMIRATES BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 125

TABLE 193 UNITED ARAB EMIRATES BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 126

TABLE 194 UNITED ARAB EMIRATES SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 126

TABLE 195 UNITED ARAB EMIRATES STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 126

TABLE 196 UNITED ARAB EMIRATES BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 127

TABLE 197 UNITED ARAB EMIRATES BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 127

TABLE 198 UNITED ARAB EMIRATES BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 128

TABLE 199 UNITED ARAB EMIRATES BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 128

TABLE 200 SAUDI ARABIA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 128

TABLE 201 SAUDI ARABIA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 129

TABLE 202 SAUDI ARABIA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 129

TABLE 203 SAUDI ARABIA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 129

TABLE 204 SAUDI ARABIA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 130

TABLE 205 SAUDI ARABIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 130

TABLE 206 SAUDI ARABIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 131

TABLE 207 SAUDI ARABIA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 131

TABLE 208 OMAN BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 131

TABLE 209 OMAN BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 132

TABLE 210 OMAN SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 132

TABLE 211 OMAN STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 132

TABLE 212 OMAN BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 133

TABLE 213 OMAN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 133

TABLE 214 OMAN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 134

TABLE 215 OMAN BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 134

TABLE 216 KUWAIT BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 134

TABLE 217 KUWAIT BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 135

TABLE 218 KUWAIT SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 135

TABLE 219 KUWAIT STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 135

TABLE 220 KUWAIT BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 136

TABLE 221 KUWAIT BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 136

TABLE 222 KUWAIT BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 137

TABLE 223 KUWAIT BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 137

TABLE 224 QATAR BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 137

TABLE 225 QATAR BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 138

TABLE 226 QATAR SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 138

TABLE 227 QATAR STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 138

TABLE 228 QATAR BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 139

TABLE 229 QATAR BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 139

TABLE 230 QATAR BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 140

TABLE 231 QATAR BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 140

TABLE 232 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 140

TABLE 233 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY PRODUCT, 2014 TO 2023 (USD MILLION) 141

TABLE 234 REST OF MIDDLE EAST & AFRICA SENSORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 141

TABLE 235 REST OF MIDDLE EAST & AFRICA STRAINS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 141

TABLE 236 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY APPLICATION, 2014 TO 2023 (USD MILLION) 142

TABLE 237 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2014 TO 2023 (USD MILLION) 142

TABLE 238 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2014 TO 2023 (USD MILLION) 143

TABLE 239 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY END USER, 2014 TO 2023 (USD MILLION) 143



FIGURE 1 GLOBAL BIOHACKING MARKET, BY TYPE, 2016 (%) 15

FIGURE 2 GLOBAL BIOHACKING MARKET, BY PRODUCT, 2016 (%) 16

FIGURE 3 GLOBAL BIOHACKING MARKET, BY APPLICATION, 2016 (%) 16

FIGURE 4 GLOBAL BIOHACKING MARKET, BY END USER, 2016 (%) 17

FIGURE 5 GLOBAL BIOHACKING MARKET, BY REGION, 2016 (%) 18

FIGURE 6 GLOBAL BIOHACKING MARKET: MARKET STRUCTURE 21

FIGURE 7 RESEARCH METHODOLOGY 22

FIGURE 8 GLOBAL BIOHACKING MARKET: FORECAST MODEL 26

FIGURE 9 DROT ANALYSIS OF GLOBAL BIOHACKING MARKET 27

FIGURE 10 GLOBAL BIOHACKING MARKET: VALUE CHAIN 35

FIGURE 11 PORTERS FIVE FORCE MODEL: GLOBAL BIOHACKING MARKET 36

FIGURE 12 GLOBAL BIOHACKING MARKET, BY TYPE, 2016 & 2023 (USD MILLION) 39

FIGURE 13 GLOBAL BIOHACKING MARKET, BY PRODUCT, 2016 & 2023 (USD MILLION) 42

FIGURE 14 GLOBAL BIOHACKING MARKET, BY APPLICATION, 2016 & 2023 (USD MILLION) 48

FIGURE 15 GLOBAL BIOHACKING MARKET, BY END USER, 2016 & 2023 (USD MILLION) 54

FIGURE 16 GLOBAL BIOHACKING MARKET, BY END USER, 2016 & 2023 (USD MILLION) 57

FIGURE 17 AMERICAS BIOHACKING MARKET, BY REGION, 2016 (%) 59

FIGURE 18 EUROPE BIOHACKING MARKET, BY REGION, 2016 (%) 73

FIGURE 19 ASIA PACIFIC BIOHACKING MARKET, BY COUNTRY, 2016 (%) 99

FIGURE 20 MIDDLE EAST & AFRICA BIOHACKIING MARKET, BY COUNTRY, 2016 (%) 122

FIGURE 21 COMPANY SHARE ANALYSIS: 2016 (%) 144